Theranica Bio-Electronics LTD.

Theranica Bio-Electronics is a digital therapeutics company specializing in neuromodulation devices for neurological pain management, particularly migraine treatment. The company develops prescription wearable devices that deliver remote electrical neuromodulation (REN) to peripheral nerves, leveraging the Conditioned Pain Modulation (CPM) mechanism—an endogenous analgesic pathway that inhibits pain through non-invasive peripheral stimulation. Their flagship product, Nerivio, is a clinically proven, drug-free wearable that stimulates upper arm peripheral nerves to trigger CPM, enabling patients to manage migraine pain without pharmaceutical intervention. The technology addresses dysfunctional pain processing in neurological conditions by delivering targeted peripheral stimuli that activate pain-inhibiting neurotransmitter release in the brain stem. Theranica's approach combines clinical rigor with accessibility, positioning digital therapeutics as a safe, affordable alternative to traditional pain management.